Cargando…
SARS-CoV-2 neutralizing antibody bebtelovimab – a systematic scoping review and meta-analysis
INTRODUCTION: The COVID-19 pandemic is a major global public health crisis. More than 2 years into the pandemic, effective therapeutic options remain limited due to rapid viral evolution. Stemming from the emergence of multiple variants, several monoclonal antibodies are no longer suitable for clini...
Autores principales: | Liew, Mabel Nyit Yi, Kua, Kok Pim, Lee, Shaun Wen Huey, Wong, Kon Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494534/ https://www.ncbi.nlm.nih.gov/pubmed/37701439 http://dx.doi.org/10.3389/fimmu.2023.1100263 |
Ejemplares similares
-
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
por: Westendorf, Kathryn, et al.
Publicado: (2022) -
N-Acetylcysteine as Adjuvant Therapy for COVID-19 – A Perspective on the Current State of the Evidence
por: Wong, Kon Ken, et al.
Publicado: (2021) -
Randomized trials of housing interventions to prevent malaria and Aedes-transmitted diseases: A systematic review and meta-analysis
por: Kua, Kok Pim, et al.
Publicado: (2021) -
Bebtelovimab-Induced Bradycardia Leading to Cardiac Arrest
por: Gearges, Christina, et al.
Publicado: (2022) -
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
por: McCreary, Erin K, et al.
Publicado: (2022)